Hidden Problems in Multiple Sclerosis: Gaps Between Patient Experience and Outcome Assessments
Andreas Lysandropoulos1, Naomi Suminski1, Tjalf Ziemssen2
1Parexel, 2University Clinic Dresden
Objective:
The aim of the study was to identify hidden problems of Multiple Sclerosis (MS) via a literature review and evaluate whether existing clinical outcome assessments (COAs) adequately assess them. 
Background:
MS clinical practice and research focus on relapses, physical disability progression, and imaging. However, meaningful symptoms and quality of life (QoL) impacts experienced by people with MS (PwMS) may be overlooked and are not well understood or assessed. 
Design/Methods:

A concept-focused literature review was conducted via PubMed to identify qualitative, patient-centered research, such as focus groups, interviews, surveys focusing on limitations and QOL impacts experienced by PwMS. A total of 225 abstracts were screened, 34 were selected for full article review, and 12 ultimately included for concept extraction. Hidden problems were defined as symptoms and QoL impacts beyond relapses and disability as measured by Expanded Disability Status Scale (EDSS), and were organized by domain into a conceptual model. A gap analysis was performed to assess whether COAs used in MS include the identified concepts.

Results:

Almost 100 concepts were extracted covering function (n=5 domains; cognition, energy/sleep, sexual, emotional, physical), daily life (n=4 domains; relationships, social life, work, daily activities) and sense of self (n=2 domains; self-efficacy, adaptive behaviour). No MS COA comprehensively assess all domains. MS Impact Scale (MSIS-29) and Fatigue Severity Scale (FSS) only measure 3 and 1 domains respectively. MS Quality of Life Inventory (MSQLI) and MSQoL-54 are the most comprehensive, measuring seven domains each.

Conclusions:

Existing COAs fail to capture the full disease experience of PwMS and therefore may not measure meaningful effect of MS therapies either. Existing COAs could be modified, or new tools created, to reflect the most salient hidden MS problems. An artificial intelligence (AI) approach combing holistic screening and assessment, could also address current gaps in measurement.

10.1212/WNL.0000000000211713
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.